Cardier Jose E, Balogh Valeria, Perez-Silva Carlos, Romano Egidio, Rivas Betty, Bosch Norma, Rothman Alan L
Laboratorio de Patología Celular y Molecular, Centro de Medicina Experimental, Instituto Venezolano de Investigaciones Científicas, IVIC, Apartado 21827, Caracas 1020-A, Venezuela.
Cytokine. 2006 May;34(3-4):155-60. doi: 10.1016/j.cyto.2006.04.002. Epub 2006 Jun 8.
Thrombocytopenia is one of the main clinical findings of dengue. In this work we examined the levels of thrombopoietin (TPO) and interleukin-11 (IL-11), two of the most potent regulators of platelet production, in serum from 28 patients with dengue fever (DF). Patients with DF had increased levels of TPO, compared with healthy individuals (p<0.005). Patients with dengue hemorrhagic fever (DHF, n=7), the more severe form of dengue, had higher TPO levels than patients with DF (p<0.001). Serum TPO levels and platelet counts were inversely correlated in both DF and DHF patients. IL-11 was detectable in neither DF nor DHF patients. Our results demonstrate that thrombocytopenia in dengue disease is associated with changes in the serum levels of TPO, but not IL-11, suggesting that this cytokine could be a potential early clinical marker of the severity of dengue disease.
血小板减少是登革热的主要临床症状之一。在本研究中,我们检测了28例登革热(DF)患者血清中血小板生成素(TPO)和白细胞介素-11(IL-11)的水平,这两种是血小板生成最有效的调节因子。与健康个体相比,DF患者的TPO水平升高(p<0.005)。登革出血热(DHF,n=7)患者,即登革热的更严重形式,其TPO水平高于DF患者(p<0.001)。DF和DHF患者的血清TPO水平与血小板计数均呈负相关。在DF和DHF患者中均未检测到IL-11。我们的结果表明,登革热疾病中的血小板减少与血清TPO水平的变化有关,而与IL-11无关,这表明这种细胞因子可能是登革热疾病严重程度的潜在早期临床标志物。